BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 19906235)

  • 1. CRH signaling. Molecular specificity for drug targeting in the CNS.
    Refojo D; Holsboer F
    Ann N Y Acad Sci; 2009 Oct; 1179():106-19. PubMed ID: 19906235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists.
    Holsboer F; Ising M
    Eur J Pharmacol; 2008 Apr; 583(2-3):350-7. PubMed ID: 18272149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress responsive neurohormones in depression and anxiety.
    Ströhle A; Holsboer F
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S207-14. PubMed ID: 14677081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
    Müller MB; Zimmermann S; Sillaber I; Hagemeyer TP; Deussing JM; Timpl P; Kormann MS; Droste SK; Kühn R; Reul JM; Holsboer F; Wurst W
    Nat Neurosci; 2003 Oct; 6(10):1100-7. PubMed ID: 12973355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
    Ströhle A
    Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior.
    Lu A; Steiner MA; Whittle N; Vogl AM; Walser SM; Ableitner M; Refojo D; Ekker M; Rubenstein JL; Stalla GK; Singewald N; Holsboer F; Wotjak CT; Wurst W; Deussing JM
    Mol Psychiatry; 2008 Nov; 13(11):1028-42. PubMed ID: 18475271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single episode of restraint stress regulates central corticotrophin- releasing hormone receptor expression and binding in specific areas of the mouse brain.
    Greetfeld M; Schmidt MV; Ganea K; Sterlemann V; Liebl C; Müller MB
    J Neuroendocrinol; 2009 May; 21(5):473-80. PubMed ID: 19302188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Getting closer to affective disorders: the role of CRH receptor systems.
    Müller MB; Wurst W
    Trends Mol Med; 2004 Aug; 10(8):409-15. PubMed ID: 15310462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved.
    Bonfiglio JJ; Inda C; Refojo D; Holsboer F; Arzt E; Silberstein S
    Neuroendocrinology; 2011; 94(1):12-20. PubMed ID: 21576930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity.
    Deussing JM; Kühne C; Pütz B; Panhuysen M; Breu J; Stenzel-Poore MP; Holsboer F; Wurst W
    J Cereb Blood Flow Metab; 2007 Aug; 27(8):1476-95. PubMed ID: 17293846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.
    Müller MB; Uhr M; Holsboer F; Keck ME
    Neuroendocrinology; 2004 Jan; 79(1):1-12. PubMed ID: 14755129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing hormone modulators and depression.
    Holsboer F
    Curr Opin Investig Drugs; 2003 Jan; 4(1):46-50. PubMed ID: 12625028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Listening to mutant mice: a spotlight on the role of CRF/CRF receptor systems in affective disorders.
    Keck ME; Ohl F; Holsboer F; Müller MB
    Neurosci Biobehav Rev; 2005; 29(4-5):867-89. PubMed ID: 15899517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential disinhibition of the neonatal hypothalamic- pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice.
    Schmidt MV; Deussing JM; Oitzl MS; Ohl F; Levine S; Wurst W; Holsboer F; Müller MB; de Kloet ER
    Eur J Neurosci; 2006 Oct; 24(8):2291-8. PubMed ID: 17042789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRF signaling: molecular specificity for drug targeting in the CNS.
    Arzt E; Holsboer F
    Trends Pharmacol Sci; 2006 Oct; 27(10):531-8. PubMed ID: 16935354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1.
    Wang XD; Labermaier C; Holsboer F; Wurst W; Deussing JM; Müller MB; Schmidt MV
    Eur J Neurosci; 2012 Aug; 36(3):2360-7. PubMed ID: 22672268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E; Schmid D; Modell S; Brunner H; Lauer CJ; Holsboer F; Ising M
    J Psychiatr Res; 2008 Oct; 42(14):1154-62. PubMed ID: 18281062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mutants for the study of corticotropin-releasing hormone receptor function: development of novel treatment strategies for mood disorders.
    Keck ME; Holsboer F; Müller MB
    Ann N Y Acad Sci; 2004 Jun; 1018():445-57. PubMed ID: 15240401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New directions in the development of antidepressants: the interface of neurobiology and psychiatry.
    Nemeroff CB
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S13-6. PubMed ID: 12404664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential uses of corticotropin-releasing hormone antagonists.
    Zoumakis E; Rice KC; Gold PW; Chrousos GP
    Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.